Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Auditor change Quarterly results Appointed director
|
PUMA BIOTECHNOLOGY, INC. (PBYI)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
07/06/2023 |
4
| Wong Alvin F (Chief Scientific Officer) has filed a Form 4 on PUMA BIOTECHNOLOGY, INC.
Txns:
| Sold 6,938 shares
@ $3.3112, valued at
$23k
|
|
07/06/2023 |
4
| NOUGUES MAXIMO F (CFO) has filed a Form 4 on PUMA BIOTECHNOLOGY, INC.
Txns:
| Sold 14,680 shares
@ $3.3112, valued at
$48.6k
|
|
07/06/2023 |
4
| Ludwig Jeffrey Jerome (Chief Commercial Officer) has filed a Form 4 on PUMA BIOTECHNOLOGY, INC.
Txns:
| Sold 12,103 shares
@ $3.3112, valued at
$40.1k
|
|
07/06/2023 |
4
| HUNT DOUGLAS M (See Remarks) has filed a Form 4 on PUMA BIOTECHNOLOGY, INC.
Txns:
| Sold 7,809 shares
@ $3.3112, valued at
$25.9k
|
|
07/06/2023 |
4
| AUERBACH ALAN H (President and CEO) has filed a Form 4 on PUMA BIOTECHNOLOGY, INC.
Txns:
| Sold 60,698 shares
@ $3.3112, valued at
$201k
|
|
06/15/2023 |
4
| WILSON TROY EDWARD (Director) has filed a Form 4 on PUMA BIOTECHNOLOGY, INC.
Txns:
| Sold 27,000 shares
@ $3.4544, valued at
$93.3k
Granted 27,000 shares
@ $0 |
|
06/15/2023 |
4
| MOYES JAY M (Director) has filed a Form 4 on PUMA BIOTECHNOLOGY, INC.
Txns:
| Sold 22,000 shares
@ $3.4532, valued at
$76k
Granted 27,000 shares
@ $0 |
|
06/15/2023 |
4
| Stuglik Brian M (Director) has filed a Form 4 on PUMA BIOTECHNOLOGY, INC.
Txns:
| Sold 9,900 shares
@ $3.4598, valued at
$34.3k
Granted 27,000 shares
@ $0 |
|
06/15/2023 |
4
| Senderowicz Adrian (Director) has filed a Form 4 on PUMA BIOTECHNOLOGY, INC.
Txns:
| Sold 27,000 shares
@ $3.4548, valued at
$93.3k
Granted 27,000 shares
@ $0 |
|
06/15/2023 |
4
| Dorval Allison (Director) has filed a Form 4 on PUMA BIOTECHNOLOGY, INC.
Txns:
| Sold 10,000 shares
@ $3.45, valued at
$34.5k
Granted 27,000 shares
@ $0 |
|
06/15/2023 |
4
| MILLER MICHAEL PATRICK (Director) has filed a Form 4 on PUMA BIOTECHNOLOGY, INC.
Txns:
| Sold 13,500 shares
@ $3.4541, valued at
$46.6k
Granted 27,000 shares
@ $0 |
|
06/15/2023 |
4
| Cesano Alessandra (Director) has filed a Form 4 on PUMA BIOTECHNOLOGY, INC.
Txns:
| Granted 27,000 shares
@ $0 |
|
06/06/2023 |
4
| Wong Alvin F (Chief Scientific Officer) has filed a Form 4 on PUMA BIOTECHNOLOGY, INC.
Txns:
| Sold 269 shares
@ $3.4498, valued at
$928 |
|
02/14/2023 |
4
| Wong Alvin F (Chief Scientific Officer) has filed a Form 4 on PUMA BIOTECHNOLOGY, INC.
Txns:
| Granted 58,601 shares
@ $0 Granted 81,399 options to buy
@ $4.39, valued at
$357.3k
|
|
02/14/2023 |
4
| NOUGUES MAXIMO F (CFO) has filed a Form 4 on PUMA BIOTECHNOLOGY, INC.
Txns:
| Granted 58,601 shares
@ $0 Granted 81,399 options to buy
@ $4.39, valued at
$357.3k
|
|
02/14/2023 |
4
| Ludwig Jeffrey Jerome (Chief Commercial Officer) has filed a Form 4 on PUMA BIOTECHNOLOGY, INC.
Txns:
| Granted 66,972 shares
@ $0 Granted 93,028 options to buy
@ $4.39, valued at
$408.4k
|
|
01/05/2023 |
4
| Wong Alvin F (Chief Scientific Officer) has filed a Form 4 on PUMA BIOTECHNOLOGY, INC.
Txns:
| Sold 3,460 shares
@ $4.1779, valued at
$14.5k
|
|
01/05/2023 |
4
| NOUGUES MAXIMO F (CFO) has filed a Form 4 on PUMA BIOTECHNOLOGY, INC.
Txns:
| Sold 10,499 shares
@ $4.1779, valued at
$43.9k
|
|
01/05/2023 |
4
| Ludwig Jeffrey Jerome (Chief Commercial Officer) has filed a Form 4 on PUMA BIOTECHNOLOGY, INC.
Txns:
| Sold 6,568 shares
@ $4.1779, valued at
$27.4k
|
|
01/05/2023 |
4
| HUNT DOUGLAS M (See Remarks) has filed a Form 4 on PUMA BIOTECHNOLOGY, INC.
Txns:
| Sold 4,225 shares
@ $4.1779, valued at
$17.7k
|
|
01/05/2023 |
4
| AUERBACH ALAN H (President and CEO) has filed a Form 4 on PUMA BIOTECHNOLOGY, INC.
Txns:
| Sold 27,241 shares
@ $4.1779, valued at
$113.8k
|
|
12/12/2022 |
4
| AUERBACH ALAN H (President and CEO) has filed a Form 4 on PUMA BIOTECHNOLOGY, INC.
Txns:
| Granted 568,181 shares
@ $4.4, valued at
$2.5M
|
|
12/06/2022 |
4
| AUERBACH ALAN H (President and CEO) has filed a Form 4 on PUMA BIOTECHNOLOGY, INC.
Txns:
| Sold 1,251 shares
@ $4.4978, valued at
$5.6k
|
|
12/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
11/04/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
11/04/2022 |
4
| AUERBACH ALAN H (President and CEO) has filed a Form 4 on PUMA BIOTECHNOLOGY, INC.
Txns:
| Sold 1,242 shares
@ $2.25, valued at
$2.8k
|
|
11/04/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
10/05/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
10/05/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
10/05/2022 |
4
| AUERBACH ALAN H (President and CEO) has filed a Form 4 on PUMA BIOTECHNOLOGY, INC.
Txns:
| Sold 1,260 shares
@ $2.3354, valued at
$2.9k
|
|
09/07/2022 |
4
| NOUGUES MAXIMO F (CFO) has filed a Form 4 on PUMA BIOTECHNOLOGY, INC.
Txns:
| Sold 164 shares
@ $2.5896, valued at
$424.7 |
|
09/07/2022 |
4
| HUNT DOUGLAS M (See Remarks) has filed a Form 4 on PUMA BIOTECHNOLOGY, INC.
Txns:
| Sold 433 shares
@ $2.5896, valued at
$1.1k
|
|
|
|
|